PetMed Express, Inc. (FRA:PQM)

PetMed Express Statistics

Total Valuation

PetMed Express has a market cap or net worth of EUR 57.31 million. The enterprise value is 27.58 million.

Market Cap	57.31M
Enterprise Value	27.58M

Important Dates

The next estimated earnings date is Monday, February 2, 2026.

Earnings Date	Feb 2, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	21.34M
Shares Outstanding	n/a
Shares Change (YoY)	+1.14%
Shares Change (QoQ)	+0.64%
Owned by Insiders (%)	7.55%
Owned by Institutions (%)	26.42%
Float	14.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.34
PB Ratio	1.56
P/TBV Ratio	1.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.59
EV / Sales	0.17
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.06

Financial Position

The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.02.

Current Ratio	1.05
Quick Ratio	0.67
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.05
Interest Coverage	-44.91

Financial Efficiency

Return on equity (ROE) is -78.89% and return on invested capital (ROIC) is -292.09%.

Return on Equity (ROE)	-78.89%
Return on Assets (ROA)	-14.11%
Return on Invested Capital (ROIC)	-292.09%
Return on Capital Employed (ROCE)	-63.74%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	976,770
Profits Per Employee	-271,076
Employee Count	173
Asset Turnover	1.61
Inventory Turnover	10.06

Taxes

In the past 12 months, PetMed Express has paid 5.24 million in taxes.

Income Tax	5.24M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.22% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-43.22%
50-Day Moving Average	2.28
200-Day Moving Average	2.55
Relative Strength Index (RSI)	47.68
Average Volume (20 Days)	64

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.42

Income Statement

In the last 12 months, PetMed Express had revenue of EUR 168.98 million and -46.90 million in losses. Loss per share was -2.26.

Revenue	168.98M
Gross Profit	49.56M
Operating Income	-23.69M
Pretax Income	-41.66M
Net Income	-46.90M
EBITDA	-16.69M
EBIT	-23.69M
Loss Per Share	-2.26

Balance Sheet

The company has 30.77 million in cash and 654,566 in debt, with a net cash position of 30.11 million.

Cash & Cash Equivalents	30.77M
Total Debt	654,566
Net Cash	30.11M
Net Cash Per Share	n/a
Equity (Book Value)	36.70M
Book Value Per Share	1.75
Working Capital	2.36M

Cash Flow

In the last 12 months, operating cash flow was -7.33 million and capital expenditures -6.04 million, giving a free cash flow of -13.36 million.

Operating Cash Flow	-7.33M
Capital Expenditures	-6.04M
Free Cash Flow	-13.36M
FCF Per Share	n/a

Margins

Gross margin is 29.33%, with operating and profit margins of -14.02% and -27.75%.

Gross Margin	29.33%
Operating Margin	-14.02%
Pretax Margin	-24.65%
Profit Margin	-27.75%
EBITDA Margin	-9.88%
EBIT Margin	-14.02%
FCF Margin	n/a

Dividends & Yields

PetMed Express does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.14%
Shareholder Yield	-1.14%
Earnings Yield	-81.83%
FCF Yield	-23.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PetMed Express has an Altman Z-Score of 2.29 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.29
Piotroski F-Score	1